Banque Cantonale Vaudoise Lantheus Holdings, Inc. Transaction History

Banque Cantonale Vaudoise

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 10, 2024	SELL	$51.07 - $68.26 $25,892 - $34,607	-507 Reduced 24.65%	1,550 $96,000
Q4 2023 Feb 07, 2024	SELL	$55.6 - $77.89 $67,220 - $94,169	-1,209 Reduced 37.02%	2,057 $128,000
Q2 2023 Aug 09, 2023	BUY	$82.41 - $99.65 $269,151 - $325,456	3,266 New	3,266 $274,000
Q2 2022 Aug 02, 2022	BUY	$55.54 - $72.65 $351,012 - $459,148	6,320 New	6,320 $417,000

541

68.3M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.08B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

Stay updated on Banque Cantonale Vaudoise with notifications on news.